In its April 2020 issue “New Zealand Optics” offers its readers an interesting highlighting about the new technologies available on the market for the treatment of dry eye.

The news focuses on our Rexon-Eye® device, capable to stimulate the natural regeneration of cells and tissues through its Quantum Molecular Resonance technology. This technology is just what makes Rexon-Eye® unique and allows it to treat all types of dry eye, both evaporative as well as aqueous deficient.

If you are interested in the article “New dry eye device unveiled” by Lesley Springall you’ll have a preview at the bottom of this page or you can follow the link below and read it on Issue, page 10.

New Zealand Optics April edition 2020.

Thanks to Eyetek Pty Ltd. for their collaboration in successfully introducing Rexon-Eye® in Australia and New Zealand.